How is your business helping to solve the health, social, or economic challenges created by COVID19?
CBio is a minority owned startup company based in Irvine, CA. CBio has been working on a point of care pathogen detection since October 2016. Our technology has demonstrated the ability to directly detect intact virus, bacteria, and other dangerous biomolecules from physiological samples (whole blood, plasma, nasal swabs, saliva).Current diagnostic tests for SARS-CoV-2 virus, reverse transcriptase poly chain reaction (RT-PCR) and serological tests suffer from the difficulties of contamination when access human material is present. The contaminants compromises the performance of these tests by degrading the signal/noise ratio. CBio has overcome the limitations of these techniques with our hardware platform, cellPhoresis®. cellPhoresis® is a live cell testing modality able to monitor viral load dynamics in cells in real time. Viral load dynamics provides better insights into the physiological state of an infected patient. Tracking this signature over time will give medical professionals the critical information they need to ensure appropriate treatment and that the treatment is working as expected.
Does your business contribute most to recovery, response, or resilience?
Resilience - we're improving the broader infrastructure for responding to pandemic outbreaks.,Recovery - we're positioned to support in the recovery of those directly affected.,Response - we're responding directly to issues caused or exacerbated by the COVID-19 outbreak.
What is the stage of your product development?
I have a prototype or a simple version I can show my customers
What strengths does your team bring? Include skills and personal experience with the problem.
CBio has a proven team with backgrounds in sales, commercialization, and product development. Founder, David Charlot, received his PhD in Bioengineering at the University of California, San Diego with specialization in building integrated systems to accelerate rare biological event detection. He is a domain expert and had an early exit from his first technology startup. During his tenure as President and CTO, he helped raise $37.5M, managed development of that companies product portfolio, and increased company value from $8M to $65M (2010-2016). Our COO and co-founder, Kat Moore, MBA, EdD, has sold over $200M in hardware and SaaS solutions since getting her MBA in 2014. Our CFO, Ken Bright, is an experienced certified public accountant with specialization in auditing, financial reporting and taxation. He has managed $75M in assets through his career as Controller for a publicly traded company, CFO of private startup, and as employee of KPMG.
What countries do you operate in?
USA
Is your company headquartered in a US "Opportunity Zone"?
No
